Your session is about to expire
← Back to Search
Study Summary
This trial looks at the effects of a single dose of a drug on the health of male volunteers.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Media Library
- You have a history of serious heart, lung, hormone, kidney, liver, stomach, blood, or mental health problems. You also have any ongoing medical condition that is not being properly controlled.You have a history of seizures or epilepsy.
- Group 1: ABBV-903
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How may I apply to be a part of this research endeavor?
"The requirements for enrolment into this medical trial are relatively straightforward: applicants must be physically healthy and between 18-55 years of age. Presently, there is capacity to accept around 7 volunteers."
Does this medicinal investigation include individuals aged over forty?
"The parameters for eligibility to this clinical trial indicate that only those aged between 18 and 55 years old can participate. Conversely, there are 57 studies available for minors and 379 studies open to elderly patients."
How many individuals are being accepted into this medical experiment?
"Affirmative, according to information hosted on clinicaltrials.gov this research project is actively searching for participants. Initially posted on August 18th 2023 and last updated on the 29th of August, this trial aims to recruit 7 individuals from a single medical centre."
Has ABBV-903 achieved the necessary regulatory clearance to be marketed?
"The safety of ABBV-903 is assessed to be a 1 as this Phase 1 trial has provided insufficient data related to its efficacy and security."
Are individuals able to enroll in this experiment at the present time?
"According to the clinicaltrials.gov, this medical study is presently accepting applications from suitable patients. It was initially advertised on August 18th 2023 and underwent its most recent update on August 29th 23rd."
Share this study with friends
Copy Link
Messenger